TAMPA, Fla. -- International Society for Pharmaceutical Engineering, a global, not-for-profit group of 25,000 pharmaceutical science and manufacturing professionals, has named Douglas Ellsworth its International Regulatory Affairs Advisor, effective July 15.
In this role Ellsworth will help expand relationships with regulatory authorities worldwide, keep ISPE Members informed about significant regulatory developments, and recommend new projects.
“We are extremely fortunate to add Doug Ellsworth to our strong regulatory team,” said Bob Best, ISPE President and Chief Executive Officer. “Doug brings 34 years of regulatory experience in some key, wide ranging positions that will enable him to guide us in our role as the ‘integrator’ of industry, regulatory authorities, and academia for the benefit of the pharmaceutical industry and the patients it serves.”
Ellsworth will retire July 3 as the District Director of the US Food and Drug Administration’s (FDA) New Jersey District. He was responsible for their investigational and enforcement activities in New Jersey, as well as outreach activities to promote voluntary compliance and consumer understanding about matters regulated by the agency.